Chester Zygmont's most recent trade in Revelation Biosciences Inc was a trade of 15,048 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on Feb. 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Revelation Biosciences Inc | Chester Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 15,048 | 15,076 | - | 3.9 | 58,236 | Common Stock |
Revelation Biosciences Inc | Chester Zygmont | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 611 | 0 | - | - | Stock Option (Right to Buy) |